$6.95 Billion is the total value of SAMLYN CAPITAL, LLC's 456 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $18,344,000 | -14.0% | 154,706 | 0.0% | 0.26% | -10.2% | |
| JCIC | JACK CREEK INVESTMENT CORP | $8,823,000 | +0.5% | 899,425 | 0.0% | 0.13% | +5.0% | |
| GLHA | GLASS HOUSES ACQUISITION COR | $8,167,000 | +0.4% | 837,591 | 0.0% | 0.12% | +4.5% | |
| GAMC | GOLDEN ARROW MERGER CORP | $3,314,000 | +0.8% | 339,720 | 0.0% | 0.05% | +6.7% | |
| LDHA | LDH GROWTH CORP I | $1,975,000 | -0.4% | 201,840 | 0.0% | 0.03% | +3.7% | |
| GLHAW | GLASS HOUSES ACQUISITION COR*w exp 03/25/202 | $144,000 | -43.3% | 422,607 | 0.0% | 0.00% | -50.0% | |
| SOMALOGIC INC*w exp 08/31/202 | $162,000 | -36.2% | 75,880 | 0.0% | 0.00% | -50.0% | ||
| JCICW | JACK CREEK INVESTMENT CORP*w exp 10/01/202 | $96,000 | -60.3% | 449,712 | 0.0% | 0.00% | -66.7% | |
| LDHAW | LDH GROWTH CORP I*w exp 03/17/202 | $16,000 | -51.5% | 42,005 | 0.0% | 0.00% | – | |
| GAMCW | GOLDEN ARROW MERGER CORP*w exp 07/31/202 | $29,000 | -50.0% | 116,604 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LPL FINL HLDGS INC | 30 | Q3 2023 | 7.7% |
| AMAZON COM INC | 30 | Q3 2023 | 4.1% |
| BIOGEN INC | 30 | Q3 2023 | 4.7% |
| VOYA FINL INC | 24 | Q3 2023 | 5.8% |
| WAYFAIR INC | 24 | Q2 2023 | 1.5% |
| CONSTELLATION BRANDS INC | 23 | Q4 2018 | 4.6% |
| BURLINGTON STORES INC | 23 | Q3 2023 | 3.7% |
| HDFC BANK LTD | 23 | Q3 2020 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 23 | Q3 2022 | 0.8% |
| ICICI BK LTD | 22 | Q1 2023 | 4.0% |
View SAMLYN CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eliem Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Glass Houses Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Perella Weinberg PartnersSold out | February 14, 2023 | 0 | 0.0% |
| Satsuma Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Falcon Minerals CorpSold out | February 14, 2022 | 0 | 0.0% |
| Sculptor Capital Management, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| FinTech Acquisition Corp. IV | February 08, 2021 | 2,913,419 | 12.3% |
| Roth CH Acquisition I Co. Parent Corp. | February 08, 2021 | 963,056 | 9.8% |
| NorthStar Realty Europe Corp.Sold out | February 14, 2018 | 0 | 0.0% |
| Osprey Energy Acquisition Corp | February 14, 2018 | 2,512,051 | 9.1% |
View SAMLYN CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-05 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View SAMLYN CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.